SUMMARY Results of the direct leucocyte migration inhibition (LMI) test using gluten fraction III as antigen were unaffected by incorporation of puromycin into the culture medium at concentrations shown to prevent lymphokine mediated inhibition. Results of the LMI test performed with purified polymorphs were similar to and correlated with results of the standard LMI test using mixed leucocytes in both coeliacs and controls. The addition of purified T lymphocytes did not increase migration inhibition. Normal leucocytes incubated with serum from coeliac patients and washed showed marked migration inhibition when incubated with gluten fraction III. This sensitisation of normal leucocytes was prevented by preincubation with aggregated human IgG. These results suggest that leucocyte migration inhibition by gluten in coeliac disease is not due to lymphokine production by sensitised lymphocytes but is caused by cytophilic antibody.
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There is considerable evidence for abnormal immunity to gluten in patients with coeliac disease' and it is suggested that this may be important in pathogenesis. In recent years attention has been focused on the role of cell mediated immunity to gluten and much of the evidence supporting the existence of such immunity comes from use of the leucocyte migration inhibition (LMI) test. 5 18 and by direct toxicity of the Received for publication 22 July 1982 putative antigen. '9 Furthermore, skin tests with gluten subfractions have shown no evidence of delayed hypersensitivity to gluten in coeliac disease.1 We have therefore further investigated the LMI test in coeliac disease using puromycin as an inhibitor of lymphokine production and using purified white cell populations to determine whether or not the assumption that results of the LMI test correlate with T-lymphocyte mediated immunity to gluten is justified. We have also investigated the possibility that a serum factor such as cytophilic antibody is involved by attempting to sensitise normal leucocytes to gluten by preincubation with sera from coeliac patients.
Methods

PATIENTS
Ten patients (seven women and three men) with coeliac disease were studied. All had typical jejunal biopsy changes at the time of diagnosis and all showed histological improvement on gluten exclusion. Mean 
Results
The effect of puromycin at 15 gtg/ml on migration indices with gluten fraction III as antigen is shown in would be expected if a lymphokine were involved. This contrasts with the effect of puromycin on migration index with purified protein derivative as antigen (Fig. 2) . With purified protein derivative alone the three Mantoux-positive subjects all showed migration inhibition which in each case was reduced by puromycin. Puromycin did not affect migration indices of the Mantoux-negative subjects. Absolute migration areas of cultures performed with puromycin alone (without antigen) did not differ significantly from those in culture medium without additives. Figure 3 illustrates the comparison of migration indices using gluten fraction III The demonstration that purified polvmorphs from 
